Neuro-Immune Receptor Cross-Talk and Pain Modulation: Analyzing the dual anti-nociceptive and anti-inflammatory properties of Palmitoylethanolamide (PEA)
Start your intake How Tirzepatide and Semaglutide Work Differently Tirzepatide activates both GLP-1 and GIP receptors, creating a dual-pathway effect that suppresses hunger and improves insulin sensitivity across two separate signaling routes
Sarcopenia affects the elderly population and typically is associated with aging
All doses of tirzepatide and semaglutide were superior to placebo in achieving at least a 10% body weight reduction, with tirzepatide 15 mg (risk ratio = 10.51 [95% CI 7.55, 14.64]) and tirzepatide 10 mg (risk ratio = 8.84 [95% CI 6.35, 12.32]) being the most efficacious treatments (ESM Table 13)
For patients on low doses (5 to 10 units), this represents 5 to 20 percent of their intended dose
According to the NZa, almost 90,000 Dutch people used Ozempic last year